The Encompass platform is a customizable molecular diagnostic system that operates interchangeable purification, amplification and detection modules organized on single-use cartridges. This modularity enables the system to be configured to run both user-designed and future FDA-cleared tests. Applications for the Rheonix CARD® are virtually endless, making the platform valuable in the IVD lab, the pathology lab and at the point of care. The Company has product development programs for infectious diseases, pharmacogenomics and environmental applications.
EncompassMDx™ is not approved by the FDA for in vitro diagnostic use; available now as an open system for research use only (RUO) assays.